Modulation of Anti-Sheep Erythrocyte Primary Antibody Response by Protein a in Normal Mice

References

• Catalona W. J., Ratliff T. I., McCool R. E. Interferon induced by S. aureus protein A augments natural killing and ADCC. Nature 1981; 291: 77
   PubMed Web of Science ®Google Scholar
• Cowan P. M., Klein D. L., Armstrong G. R., Pearson J. W. Augmentation and inhibition of delayed hypersensitivity by Staphylococcus aureus protein A. Biomedicine 1979; 30: 241
   PubMedGoogle Scholar
• Kronvall G., Gewurz J. Activation of IgG activated complement fixation by staphylococcal protein A. Clin. Exp. Immunol. 1970; 7: 211
   PubMed Web of Science ®Google Scholar
• Prasad A. K., Singh K. P., Saxena A. K., Mathur N., Ray P. K. Increased macrophage activity in protein A treated tumor regressed animals. Immunopharmacol. Immunotoxicol. 1987; 9: 541
   PubMed Web of Science ®Google Scholar
• Singh K. P., Saxena A. K., Prasad A. K., Dwivedi P. D., Zaidi S. I.A., Ray P. K. Effect of protein A on mast cell numbers and macrophage phagocytic activity. Immunopharmac. Immunotoxicol. 1987; 2&3: 281
   Google Scholar
• Singh K. P., Zaidi S. I.A., Raisuddin, Saxena A. K., Dwivedi P. O., Ray P. K. Protection against carbon tetrachloride induced lymphoid organotoxicity in rats by protein A. Toxicol. Lett. 1990; 51: 339
   PubMedGoogle Scholar
• Ray P. K., Raychaudhuri S., Allen P. Mechanism of regression of mammary adenocarcinomas in rats following plasma adsorption over protein A containing Staphylococcus aureus. Cancer Res. 1982; 42: 4970
   PubMed Web of Science ®Google Scholar
• Zaidi S. I.A., Singh K. P., Raisuddin, Saxena A. K., Ray P. K. Protein A induced abrogation of cyclophosphamide toxicity is associated with concomitant potentiation of immune function of host. Immunopharmacol. Immunotoxicol. 1990; 12: 479
   PubMed Web of Science ®Google Scholar
• Ray P. K., Bandyopadhyay S. Inhibition of rat mammary tumor growth by purified protein A:a potential antitumor agent. Immunol. Commun. 1983; 12: 453
   PubMed Web of Science ®Google Scholar
• Ray P. K., Bandyopadhyay S., Dohadwala M., Canchanapan P., Mobini J. Antitumor activity with nontoxic doses of protein A. Cancer Immunol. Immunother. 1984; 18: 29
   PubMed Web of Science ®Google Scholar
• Ray P. K., McLaughlin D., Allen P., Bandyopadhyay S., Idiculla A., Bassett J. G., Cooper D. R. Adsorption of plasma from tumor bearing host over protein A containing nonviable Staphylococcas aiireus Cowan I: possible mechanism of antitumor reaction. J. Biol. Res. Modif. 1984; 3: 293
   PubMedGoogle Scholar
• Ray P. K., McLaughlin D., Mohammed J., Idiculla A., Rhoads I. E., Jr, Mark R., Bassett J. G., Cooper D. R. Exvivo immunoadsorption of IgG or its complexes, a new modality of cancer treatment. Immune complexes and plasma exchanges in cancer patients, B. Serroui, C. Rosenfeld. Elsevier, North-Holland 1981
   Google Scholar
• Dohadwala M., Ray P. K. In vivo protection by protein A of hepatic microsomal mixed oxygenase system of cyclophosphamide treated rats. Cancer Chemother. Pharmacol. 1984; 14: 135
   Web of Science ®Google Scholar
• Srivastava S. P., Singh K. P., Saxena A. K., Seth P. K., Ray P. K. In vivo protection by protein A of hepatic microsomal mixed function oxidase system of CC14, administered rats. Biochem. Pharmacol. 1987; 36: 4055
   PubMed Web of Science ®Google Scholar
• Dwivedi P. O., Verma A. S., Mishra A., Singh K. P., Prasad A. K., Saxena A. K., Dutta K. K., Mathur N., Ray P. K. Protein A protects mice from depletion of biotransformation enzymes and mortality induced by Salmonella typhimurium endotoxin. Toxicol. Lett. 1989; 49: 1
   PubMed Web of Science ®Google Scholar
• Luster M. I., Dean J. H., Moore J. A. Evaluation of immune function in toxicology. Principles and Methods of Toxicology, A W Hayes. Raven Press, New York 1982; 561
   Google Scholar
• Cunningham A. J. Method of increased sensitivity for detecting single antibody forming cells. Nature 1965; 207: 1106
   PubMed Web of Science ®Google Scholar
• Munson A. E., Sanders V. M., Douglas K. A., Sain L. E., Kauffmann B. M., White K. L., Jr. In vivo assessment of immunotoxicity. Env. Health. Perspect. 1982; 43: 41
   PubMed Web of Science ®Google Scholar
• Ray P. K., Dohadwala M., Bandyopadhyay S. K., Canchanapan P., McLaoughlin D. Rescue of rats from large dose cyclophosphamide toxicity using protein A. Cancer Chemother. Pharmacol. 1985; 14: 59
   PubMed Web of Science ®Google Scholar
• O'Malley J. A., Nussbaum-Blumenson A., Sheddy D., Grossmayer B. J., Ozer H. Identification of the T cell subset that produces human gamma interferon. J. Immunol. 1982; 128: 2522
   PubMed Web of Science ®Google Scholar
• Olenescu A., Hristecu S., Sjoquist J., Ghetie V. Correlation between the triggering of proliferation and the potentiation of NK activity induced by protein A in human lymphocytes. Immun. Lett. 1983; 6: 231
   PubMed Web of Science ®Google Scholar
• Dosset J., Kronvall G., Williams R. C., Quie P. O. Antiphagocytic effects of staphylococcal protein A. J. Immunol. 1969; 103: 1405
   Web of Science ®Google Scholar
• Patel P. C., Stefanescu-Soare I., Menezes J. Staphylococcal protein A enhances NK activity against lymphoid tumor cell lines. Int. J. Cancer. 1981; 28: 277
   PubMedGoogle Scholar
• Ghaffar A., Sigel M. M. Immunomodulation by Corynebacterium parvum 1. Variable effects on anti-sheep erythrocyte antibody response. Immunol. 1978; 35: 685
   PubMed Web of Science ®Google Scholar
• Olivotto M., Bomford R. In vitro inhibition of tumor cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum. Int. J. Cancer 1974; 13: 478
   PubMed Web of Science ®Google Scholar
• Ghaffar A., Cullen R. T., Woodruff M. F.A. Further analysis of the antitumor effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum. Br. J. Cancer 1975; 31: 15
   PubMedGoogle Scholar
• Otu A. A., Russell R. J., White R. G. Biphasic pattern of activation of the reticuloendothelial system by anaerobic Coryneforms in mice. Immunology 1977; 32: 255
   PubMedGoogle Scholar
• Keller R. Cytostatic elimination of syngeneic rat cells in vitro by nonspecifically activated macrophages. J. Exp. Med. 1973; 138: 625
   PubMed Web of Science ®Google Scholar
• Keller R. Susceptibility of normal and transformed cell lines to cytostatic and cytocidal effects exerted by macrophages. J. Nati. Cancer Inst. 1976; 56: 369
   PubMedGoogle Scholar
• Scott M. T. Biological effect of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. Cell. Immunol. 1972; 5: 459
   PubMed Web of Science ®Google Scholar
• Ratliff T. R., McDermott R. P., Poepping N. J., Oakley D. M., Shapiro A., Catalona W. Production of gamma interferon by human T and null cells and its regulation by macrophages. Cell. Immunol. 1982; 74: 111
   PubMed Web of Science ®Google Scholar
• Smith E. M., Johnson H. M., Blalock I. E. Staphylococcus aureus protein A induces the production of interferon-a in human lymphocytes and interferon-α/ß in mouse spleen cells. J. Immunol. 1983; 130: 773
   PubMed Web of Science ®Google Scholar
• Ducatenzeiler A., Menezes J. Human gamma interferon induction by staphylococcal protein A:effector cells, kinetics and the effect of prostaglandin, indomethacin, ibrufen and aspirin. Int. J. Immunopharmac. 1988; 10: 81
   PubMed Web of Science ®Google Scholar
• Fleischer B. Induction of T cell growth factor synthesis in human peripheral blood lymphocytes by staphylococcal protein A. J. Immun. Meth. 1981; 47: 191
   PubMed Web of Science ®Google Scholar
• Braun W., Levy H. B. Interferon preparations as modifiers of immune responses. Proc. Soc. Exp. Biol. Med. 1972; 141: 769
   PubMed Web of Science ®Google Scholar
• Chester T. J., Paucker K., Merigan T. C. Suppression of mouse antibody producing cells by various interferon productions. Nature 1973; 246: 92
   PubMed Web of Science ®Google Scholar
• Brodeur B. R., Merigan T. C. Mechanism of suppressive effect of interferon on antibody synthesis in vivo. J. Immunol. 1975; 114: 1323
   PubMed Web of Science ®Google Scholar
• Gisler R. H., Lindahl P., Gresser I. Effects of interferon on antibody synthesis in vitro. J. Immunol. 1974; 113: 438
   PubMed Web of Science ®Google Scholar
• Johnson H. M., Smith B. C., Baron S. Inhibition of the primary in vitro antibody response by interferon preparations. J. Immunol. 1975; 114: 403
   PubMed Web of Science ®Google Scholar
• Gresser I., DeMaeyer-Guignard J., Torey M. G., DeMaeyer E. Electrophoretically pure mouse interferon exerts multiple biological effects. Proc. Natl. Acad. Sci. USA 1979; 76: 5308
   PubMed Web of Science ®Google Scholar
• Sonnenfeld G. Modulation of immunity by interferon. Lymphokine,Rep. 1980; 1: 113
   Google Scholar
• De Maeyer-Guignard J., De Maeyer E. Immunomodulation by interferons: Recent developments. Interferon 1985; 6: 69
   PubMedGoogle Scholar
• Wietzerbin J., Stephenos S., Falcoff R., Falcoff E. Some properties of interferons induced by stimulants of T and B lymphocytes. Tex. Rep. Biol. Med. 1977; 35: 205
   PubMedGoogle Scholar
• Johnson H. M., Baron S. The nature of suppressive effect of interferon inducers on the in vitro immune response. Cell. Immunol. 1976; 25: 106
   PubMed Web of Science ®Google Scholar
• Johnson H. M., Stanton G. J., Baron S. Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Pros. Soc. Exp. Biol. Med. 1977; 154: 138
   PubMed Web of Science ®Google Scholar
• Strannegard O., Larsson I., Lundgren I., Miorner H., Persson H. Modulation of immune responses in new born and adult mice by interferon. Infect. Immun. 1978; 20: 334
   PubMedGoogle Scholar
• Johnson H. M., Blalock J. E. Interferon immunosuppression: mediation by a suppressor factor. Infect. Immun. 1980; 29: 301
   PubMedGoogle Scholar
• Aune T. M., Pierce C. W. Activation of suppressor T-cell pathway by interferon. Proc. Natl. Acad. Sci. USA. 1982; 79: 3808
   PubMedGoogle Scholar
• Schrezenmeier H., Fleischer B. Mitogenic activity of Staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J. Immunol. Methods 1987; 105: 133
   PubMed Web of Science ®Google Scholar
• Persson U., Inganas M., Smith C. I., Hammarstrom I., Johansson S. G. Recombinant protein A of non-staphylococcal origin is not mitogenic for human peripheral lymphocytes. Mitogenicity of natural protein A is caused by a contaminant. Scand. J. Immunol. 1989; 29: 151
   PubMed Web of Science ®Google Scholar
• Singh K. P., Shau H., Gupta P. K., Kopald K., Ray P. K. Protein A potentiates lymphokine-activated killer cell induction in normal and melanoma patient lymphocytes. Immunopharmac. Immunotoxicol. 1992; 14: 79
   Web of Science ®Google Scholar
• Das C., Langone J. J. Dissociation between murine spleen cell mitogenic activity of staphylococcal protein A. J. Immunol. 1989; 142: 2943
   PubMedGoogle Scholar
• Baldwin R. W., Price M. R., Robbins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma-cells by tumour-specific antigen antibody complexes. Nature-Biol. 1972; 238: 185
   Google Scholar